CADL compared with URGN: revenue, margins and what each company keeps, and the suppliers and customers both name

CADLCandel Therapeutics, Inc.

Mkt capRevenueRevenue

URGNUroGen Pharma Ltd.

Mkt capRevenueRevenue

Compare

CADLCandel Therapeutics, Inc.

URGNUroGen Pharma Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CADL 0

None

Shared 0

No disclosed counterparties: CADL.

Only URGN 6

AGENAgenussupplier

TEVATeva Pharmaceuticals Industriessupplier

—Cenexi-Laboratories Thissenunlistedsupplier

—IconOVir Biounlistedsupplier

2 more · URGN chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CADLCandel Therapeutics, Inc.

8.12▼−2.56%· post 8.12

Mkt cap$637.4MRevenue—Revenue—

URGNUroGen Pharma Ltd.

32.70▼−0.06%· post 34.42

ClosedNov 2 '26

Mkt cap$1.6BRevenue$72MQ2 FY26Revenue$110MFY25

Compare

ClosedNov 2 '26

CADLCandel Therapeutics, Inc.

URGNUroGen Pharma Ltd.

8.12▼−2.56%post 8.12

Price

32.70▼−0.06%post 34.42

$637.4M

Mkt cap

$1.6B

—

Revenue

$72MQ2 FY26

—

Revenue

$110MFY25

CADL8.12▼−2.56%vsURGN32.70▼−0.06%ClosedNov 2 '26